Cardiology Containment Regulation 
Pharmaceutical Technology
MAY 26, 2023
John Hertig, the president of the board of directors for the nonprofit Alliance for Safe Online Pharmacies (ASOP) Global says, “Counterfeit products sold by illegal online pharmacies often are manufactured in unsafe conditions, contain little or no active ingredients and/or are manufactured using dangerous and sometimes deadly substances.”
The Pharma Data
DECEMBER 12, 2020
It plays a crucial role in many inflammatory and autoimmune diseases across multiple therapy areas, including haematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. The complement cascade is pivotal to the innate immune system. Morgan Stanley & Co. Morgan Cazenove) (“J.P.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 4, 2020
Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. This press release and further information about Alexion can be found at: www.alexion.com. Forward-Looking Statement.
The Pharma Data
OCTOBER 14, 2020
Michael Felker, MD, MHS, FACC, FAHA, FHFSA is Professor of Medicine with tenure in the Division of Cardiology at Duke University School of Medicine. He is Director of Cardiovascular Research at the Duke Clinical Research Institute and Vice-Chief for Clinical Research in the Division of Cardiology. About Dr. Udelson James E.
The Pharma Data
AUGUST 30, 2021
Results were presented at the ESC Congress 2021, organized by the European Society of Cardiology (ESC). This media update contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. reduction in LDL-C from baseline to Day 510 compared with placebo ( P < 0001) 1.
The Pharma Data
JANUARY 12, 2021
Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders, cardiology and ophthalmology. This press release and further information about Alexion can be found at: www.alexion.com.
The Pharma Data
AUGUST 29, 2020
Presented at the ESC Congress 2020, the annual meeting of the European Society of Cardiology, the analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies of more than 2,300 patients (of which 1,164 were on inclisiran) from the Phase III trials.
Expert insights. Personalized for you.
130 
Let's personalize your content